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Collagen density regulates the activity of
tumor-infiltrating T cells
Dorota E. Kuczek1, Anne Mette H. Larsen1,3, Marie-Louise Thorseth1, Marco Carretta1, Adrija Kalvisa4,
Majken S. Siersbæk4, Ana Micaela C. Simões1, Anne Roslind5, Lars H. Engelholm2, Elfriede Noessner6, Marco Donia1,
Inge Marie Svane1, Per thor Straten1,7, Lars Grøntved4 and Daniel H. Madsen1,8*
Abstract
Background: Tumor progression is accompanied by dramatic remodeling of the surrounding extracellular matrix
leading to the formation of a tumor-specific ECM, which is often more collagen-rich and of increased stiffness.
The altered ECM of the tumor supports cancer growth and metastasis, but it is unknown if this effect involves
modulation of T cell activity. To investigate if a high-density tumor-specific ECM could influence the ability of T cells
to kill cancer cells, we here studied how T cells respond to 3D culture in different collagen densities.
Methods: T cells cultured in 3D conditions surrounded by a high or low collagen density were imaged using
confocal fluorescent microscopy. The effects of the different collagen densities on T cell proliferation, survival, and
differentiation were examined using flow cytometry. Cancer cell proliferation in similar 3D conditions was also
measured. Triple-negative breast cancer specimens were analyzed for the number of infiltrating CD8+ T cells and
for the collagen density. Whole-transcriptome analyses were applied to investigate in detail the effects of collagen
density on T cells. Computational analyses were used to identify transcription factors involved in the collagen
density-induced gene regulation. Observed changes were confirmed by qRT-PCR analysis.
Results: T cell proliferation was significantly reduced in a high-density matrix compared to a low-density matrix
and prolonged culture in a high-density matrix led to a higher ratio of CD4+ to CD8+ T cells. The proliferation of
cancer cells was unaffected by the surrounding collagen-density. Consistently, we observed a reduction in the
number of infiltrating CD8+ T-cells in mammary tumors with high collagen-density indicating that collagen-density
has a role in regulating T cell abundance in human breast cancer.
Whole-transcriptome analysis of 3D-cultured T cells revealed that a high-density matrix induces downregulation of
cytotoxic activity markers and upregulation of regulatory T cell markers. These transcriptional changes were
predicted to involve autocrine TGF-β signaling and they were accompanied by an impaired ability of tumor-
infiltrating T cells to kill autologous cancer cells.
Conclusions: Our study identifies a new immune modulatory mechanism, which could be essential for suppression
of T cell activity in the tumor microenvironment.
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Solid tumors consist of cancer cells interacting with the
tumor microenvironment, which includes stromal cells,
immune cells, and the extracellular matrix. Infiltration
of tumors by lymphocytes, and in particular CD8+ cyto-
toxic T cells, is known to predict good prognosis in
many types of cancer [1]. T cell infiltration into solid
tumors is also associated with increased clinical efficacy
of immunotherapies [2]. The beneficial effect of a high
abundance of tumor-infiltrating T cells reflects the abil-
ity of the immune cells to mount a response against
cancer cells [3]. As an important way for the cancer cells
to evade immune destruction, tumors can develop a
strongly immunosuppressive tumor microenvironment
[4–6]. This includes the accumulation of cell types with
immunosuppressive activity, such as tumor-associated
macrophages (TAMs), myeloid-derived suppressor cells
(MDSCs), and regulatory T cells (Tregs) [4]. Upregula-
tion of PD-L1 by cells in the tumor microenvironment
constitutes an important and well-studied immune es-
cape mechanism in which the interaction with its recep-
tor PD-1 on T cells lead to inactivation of the T cells [7].
Antibody-mediated blockade of the PD1-PD-L1 inter-
action has demonstrated remarkable clinical efficacy for
many cancer patients and stimulated the research aiming
at identifying additional targetable immunosuppressive
mechanisms in the tumor microenvironment [7].
In addition to non-malignant stromal cells and im-
mune cells, the tumor microenvironment consists of the
extracellular matrix (ECM). Degradation of the ECM
surrounding a tumor is an essential part of invasive
cancer growth and a main reason for the destruction of
the normal tissue [8–10]. Of central importance, the
degradation of the ECM is accompanied by the depos-
ition of a different tumor-specific ECM [11]. This new
ECM is often of increased density and stiffness, and
contains components that are not typically present in
the original ECM [12, 13]. Within the last decade, a
number of important discoveries have emphasized how
the ECM can affect cancer biology [14, 15]. A strong
correlation between the density of collagen type I, which
is the most abundant component of the tumor ECM,
and poor prognosis of breast cancer, gastric cancer and
oral cancer has been demonstrated [16–18], and in vitro
studies have shown that a high-density and stiff ECM
can induce a process in epithelial cells resembling malig-
nant transformation [19–21]. Other cell types such as
fibroblasts and mesenchymal stem cells have also been
demonstrated to respond to the mechanical properties
of the surrounding ECM by a process termed cellular
mechanosensing [22, 23]. Through the effects on cancer
cells and stromal cells, the ECM can augment many of
the hallmarks of cancer, such as the induction of angio-
genesis [24] and the activation of invasion and metastasis
[15, 25]. It remains quite speculative if the ECM can also
modulate the immunosuppressive tumor microenviron-
ment and thereby support the cancer’s evasion of immune
destruction [15, 26]. It should, however, be noted that the
presentation of antigens linked to a stiff surface has been
demonstrated to impair TCR-mediated T cell activation,
suggesting that T cells possess mechanosensing abilities
[27] and others have confirmed that the TCR is affected
by mechanical force [28]. Furthermore, tumor-associated
remodeling of the ECM, can lead to the deposition of
ECM components such as osteopontin, SPARC, versican,
and tenascin C, which have been suggested to possess
immunosuppressive properties [29–31].
Although cell culture in 3D environments is widely
used in the field of cancer biology [32], 3D culture of T
cells is less common and has mainly been used for the
study of cell migration [33, 34]. The interaction between
collagen and tumor-infiltrating T cells was, however,
studied by Salmon et al. through the use of elegant ex
vivo culture of lung tumor slices combined with
real-time imaging [35]. Here, collagen fibers were sug-
gested to prevent the migration of T cells from the stro-
mal compartment into the tumor islets. Collagen-density
mediated inhibition of directional T cell migration has
also been suggested as the reason for intratumoral T cell
exclusion in pancreatic cancers [36]. It was not ad-
dressed in these studies if the collagen also influences
the activity of the T cells. In this study, we employed 3D
culture assays to investigate if the collagen-density can
directly impact the activity of T cells.
Materials and methods
T cell isolation and culture
Human peripheral blood mononuclear cells (PBMCs)
were isolated from healthy donors by gradient centrifu-
gation using Lymphoprep (Alere AS) separation and
frozen in fetal calf serum (Sigma Aldrich) with 10%
DMSO (Sigma Aldrich). For RNAseq experiments, the
PBMCs were enriched for T cells by allowing the cells to
adhere overnight and collecting only the non-adherent
and loosely adherent cells. For confocal microscopy, T
cells were isolated from healthy donors at the Combined
Technical Research Core facilities at the National Insti-
tute of Dental and Craniofacial Research (NIDCR), NIH
using elutriation. For all other experiments, T cells were
isolated from PBMCs using magnetic anti-CD3 microbe-
ads (Miltenyi Biotec) according to the manufacturer’s
instruction. Cells were cultured at 37 °C in a humidified
5% CO2 environment in X-vivo media (Sartorius) with
5% human serum (Sigma Aldrich).
3D culture in collagen gels
Type I collagen gels were prepared using a modified
protocol from Artym and Matsumoto [37]. Briefly, cells
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were resuspended in a mix of rat tail collagen type I
(Corning), 0.02 N acetic acid, 10x DMEM with Phenol
Red (Sigma Aldrich) and 10x reconstitution buffer
(0 .2M Hepes (Gibco) and 0.2 62M NaHCO3). To
neutralize the pH, 2 N NaOH was added to the reconsti-
tution buffer before use. For all cell lines, low density
(LD) and high density (HD) gels contained 1 mg/ml and
4mg/ml collagen type I respectively. First, 300 to 400 μl
of the collagen solution was plated per well of a
non-tissue culture treated 24-wells plate (Corning) and
allowed to polymerize at 37 °C for at least 30 min. After-
wards a second layer of collagen solution containing the
cells was seeded on top of the first gel and allowed to
polymerize for 1–2 h at 37 °C, after which 600 μl of
culture media was added. For culturing cells in 2D
conditions, the same number of cells were seeded in the
wells of a tissue culture treated 24-well plate.
T cell proliferation assay
T cells from healthy donors were transiently stimulated
with 10 nM PMA (Sigma Aldrich) and 175 nM ionomy-
cin (Sigma Aldrich) and labelled with CellTrace Violet
dye (Thermo Fisher Scientific). 8 × 105 T cells were
seeded in each well within LD or HD collagen gels or on
tissue culture plastic. After 5 days of culture in 3D colla-
gen gels or on plastic (2D), cells were treated with 3 mg/
ml collagenase (Worthington) solution for 45–60min at
37 °C to extract the cells from the gels, washed once
with media and once with DPBS and resuspended in
FACS buffer containing the following: Live/Dead Fixable
Near-IR Dead cell stain (Thermo Fisher Scientific),
anti-CD3-APC (cl. SK7), anti-CD4-PE (cl. SK3), and
anti-CD8-FITC (cl. HIT8a) (all BD Biosciences). Cells
were incubated with the antibodies in the dark at 4 °C
for 30 min, washed twice with FACS buffer, resuspended
in FACS buffer and acquired using a BD FACSCanto II
flow cytometer (BD Biosciences). Analysis was per-
formed with FlowJo V10 software. Experiments were
repeated three times using T cells isolated from different
donors.
T cell proliferation was also measured using the APC
BrdU Flow Kit (BD Biosciences) according to the manu-
facturer’s instructions. Briefly, 8 × 105 T cells were
seeded in each well within LD or HD collagen gels or on
tissue culture plastic for 3 days. For labelling, BrdU was
added to the medium of each well (final concentration
10 μM) and cells were incubated for 90 min at 37 °C in
5% CO2. Afterwards, media of the wells with collagen gels
was aspirated and replaced with 3mg/ml collagenase
solution (Worthington). Collagenase was also added to
the media of 2D cultured cells in concentration similar to
which cells in 3D gels were exposed. After complete
digestion of the collagen gels, cells were collected and
washed once with DPBS (Lonza) and stained with Live/
Dead Fixable Near-IR Dead cell stain (Thermo Fisher
Scientific), anti-CD3-FITC (cl- UCHT1), anti-CD4-PE (cl.
SK3), and anti-CD8-BV421 (cl. RPA-T8) (all BD Biosci-
ences). Next, cells were fixed, permeabilized, and stained
with APC anti-BrdU antibody according to the manufac-
turer’s instructions. Cells were resuspended in FACS
buffer and acquired using a BD FACSCanto II or LSR II
flow cytometer (BD Biosciences). Analysis was performed
with FlowJo V10 software.
Cancer cell proliferation assay
Cell proliferation was determined using the APC BrdU
Flow Kit (BD Biosciences). 50.000 cells were cultured in
the different 3D or 2D culture conditions for 5 days. For
labelling, BrdU was added to the medium of each well
(final concentration 10 μM) and cells were incubated for
45 min at 37 °C in 5% CO2. After digestion of collagen
gels and washing, cells were stained with Zombie Aqua
Fixable Viability Dye (BioLegend) to determine cell
viability and analyzed for the fraction of BrdU positive
cells as described above.
RNA extraction, cDNA synthesis and quantitative real-
time-PCR
For RNA isolation, 8 × 105 PBMCs enriched for T cells,
purified T cells (isolated with anti-CD3 microbeads,
Miltenyi Biotec), or purified CD8 positive cells (isolated
with CD8 MicroBeads, Miltenyi Biotec) were transiently
stimulated with PMA and ionomycin and seeded within
LD or HD collagen gels or on tissue culture plastic.
After 2 days, total RNA from cell cultures was purified
using RNeasy kit (Qiagen) according to the manufac-
turer’s instructions. Quality of samples was measured
using an Agilent 2100 BioAnalyzer (Agilent Genomics).
Afterwards 500 ng – 1 μg RNA per sample was reverse
transcribed using iScript cDNA Synthesis Kit (Bio-Rad).
The synthesized cDNA was used as template in a
real-time quantitative PCR reaction using Brilliant III
Ultra-Fast SYBR Green (Agilent Technologies) according
to the manufacturer’s standard protocol. Equal amounts
of cDNA were applied in each reaction mixture. As a
control for the specificity of the quantitative real-time
PCR, a sample without template was included. The
real-time cycler conditions were as follows: initial activa-
tion step at 95 °C for 3 min, 40 cycles of denaturing at
95 °C for 5 s, and annealing/extension at 60 °C for 20 s,
followed by a melting curve analysis of 65–95 °C with
0 .5°C increment, 5 s per step.
All measurements were based on triplicates or quadru-
plicates of each cell culture condition measured in
duplicates and normalized to the internal control gene,
ACTB. Four independent experiments were performed.
The comparative cycle threshold (ΔΔCT) method was
used to calculate the relative fold changes.
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Primers were designed using the Primer-BLAST tool
(NCBI, NIH). All primers spanned exon-exon junction,
and maximum product length was 250 bp. Primer
efficiencies were measured for all primer sets and found
to be between 85 and 103%. Primers are listed in
Additional file 1: Table S2.
T cell cultures from three different healthy donors
were established and transduced with high affinity
MAGE-A3a3a, MAGE-A3a3c, or MART-1 TCR, respect-
ively, as previously described [38]. For MART-1 TCR
transduction, the TCRα and β sequences of the
HLA-A2-restricted MART-1-specific (MART_27–36:
ELAGIGILTV) A42 T cell clone were used [39].
1 × 106 TCR transduced T cells were embedded in
collagen of high (4 mg/ml) or low (1 mg/ml) density
together with 1 × 105 FM82 melanoma cells [38] and
cultured for 2 days, after which total RNA was purified.
Extensive T cell-mediated melanoma cytotoxicity during
the co-culture period resulted in the presence of even
fewer melanoma cells as compared to the starting point.
RNAseq
The quantity and purity of isolated RNA were assessed
using an Agilent 2100 BioAnalyzer (Agilent Genomics).
Total RNA (500 ng) was prepared for sequencing using
polydT-mediated cDNA synthesis in accordance with
the manufacturer’s (Illumina) instructions. Libraries were
made with a NEBNext RNA Library Preparation Kit for
Illumina. Library quality was assessed using Fragment
Analyzer (AATI), followed by library quantification
(Illumina Library Quantification Kit). Sequencing was
done on a HiSeq1500 platform (Illumina) with a read
length of 50 bp. Sequenced reads were aligned to the hu-
man genome assembly hg19 using STAR [40]. Uniquely
aligned reads were quantified at exons of annotated
genes and normalized to sequence depth and gene
length using HOMER [41]. Sequencing depth and
alignment information is in Additional file 1: Table S3.
The number of reads per kilobase per million mapped
(RPKM) for all RefSeq annotated genes can be found in
Additional file 2: Table S1. The analysis of differential
expression was performed using DESeq2 package in R
[42]. Principal component analysis was performed using
R (prcomp package). Heatmaps were generated from
z-score normalized RPKM values using R (pheatmap
package) on selected sets of genes. MA and Volcano
plots were generated using R.
Cytotoxicity assay
A 51Cr-release assay for T cell-mediated cytotoxicity was
used to assess the cytotoxicity of tumor infiltrating T
cells after 3D culture in collagen matrices of high or low
density. Autologous melanoma cells MM33 were used as
target cells [43]. Effector cells (T cells) were pre-cultured
on plastic or in 3D collagen cultures for 3 days, after
which cells were treated with 3 mg/ml collagenase
solution for 45–60min to extract them from the gels,
and washed twice with media. Typically, 5 × 105 target
cells in 150 μl RPMI were labelled with 20 μl 51Cr (Per-
kin Elmer) in a 15ml falcon tube at 37 °C for 1 h. After
washing, 5 × 103 target cells per well were plated out in
a 96-well plate (Corning) and T cells were added at
various effector to target cell (E:T) ratios. Cells were
incubated at 37 °C for 4 h. Next, the level of 51Cr in the
supernatant was measured using a Wallac Wizard 1470
automatic γ counter (Perkin Elmer). The maximum 51Cr
release was determined by addition of 100 μl 10% Triton
X-100, and minimum release was determined by
addition of 100 μl of RPMI to target cells. Specific lysis
was calculated using the following formula: ((cpm sample
– cpm minimum release)/(cpm maximum release – cpm minimum
release)) × 100%.
Statistical analysis
All individual experiments were performed at least three
times with at least three replicates per condition and
results are presented as mean ± standard error of the
mean (SEM) unless otherwise specified. For two-group
comparisons between cells from the same donors, paired
two-tailed Student’s t-tests were performed. For
multi-group comparisons, one-way analysis of variance
(ANOVA) was used followed by paired two-tailed
Student’s t-tests. All statistical analyses were performed
using GraphPad Prism. A p-value < 0.05 was considered
statistically significant. Correlation between PSR-positive
area and CD8+ cell abundance was analyzed by Pearson
correlation.
Correlation of expression levels of collagen and T cell
activation markers in oral cancer
To study the correlation between collagen type I
(COL1A1) levels and the expression level of 7 markers of
T cell activation, we used an already published
single-cell RNA sequencing dataset available in the
Gene Expression Omnibus (GSE103322). In the study
by Puram et al. [44], head and neck tumors from 18
patients and 5 matching lymph nodes were disaggregated,
sorted into single cells and profiled using Smart-seq2.
Here, we used the already processed data discarding
lymph node samples (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE103322), which contain expression
levels of 23,686 genes in 4541 single-cells (including fibro-
blasts, B cells, T cells, dendritic cells, endothelial cells,
macrophages, mast cells, myocytes, and cancer and
non-cancer cells). To investigate correlation between col-
lagen and T cell activation markers, we first calculated
average expression levels of COL1A1 across all cell types
and expression of each T cell marker across T cells for
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each patient. Then, we calculated pairwise Pearson correl-
ation between average expression levels of COL1A1 and
each T cell activation marker. All data processing and cor-
relation analysis were performed using Pythons SciPy and
Pandas [45].
Additional materials and methods
Detailed information about cancer cell culture, confocal
microscopy, flow cytometry analysis of T cell subsets, hist-
ology, and ELISA can be found in the Additional file 3.
Results
3D culture of T cells in different collagen densities
impairs proliferation without compromising viability
To investigate if 3D culture in collagen matrices of
different collagen concentrations affected the viability of
T cells, we isolated T cells from healthy donors and tran-
siently stimulated the cells with PMA and ionomycin.
This type of stimulation bypasses T cell receptor activa-
tion but acts on several of the same downstream signal-
ing pathways including Protein Kinase C [46]. The T
cells were embedded in collagen matrices of high (4 mg/
ml) or low (1 mg/ml) collagen concentration, or seeded
on regular tissue culture plastic (2D culture) and cul-
tured for 5 days. The selected collagen concentration of
1 mg/ml is representative of healthy normal tissue such
as lung or mammary gland whereas 4 mg/ml collagen
gels mimic the tissue stiffening occurring in solid tumors
[19, 47]. To completely avoid cellular contact with the
plastic surface of the wells, the 3D culture was
established on top of a pre-generated collagen matrix
without cells (Fig. 1a). To evaluate if viability of the T
cells was affected by the different culture conditions,
cells were extracted from the collagen matrices by a brief
collagenase-treatment, stained with a live/dead cell
marker and analyzed by flow cytometry (Fig. 1b). A high
viability of more than 95% was observed in both 2D cul-
ture and in 3D culture in different collagen densities. To
visualize the 3D culture of T cells in collagen matrices of
different collagen concentrations, purified T cells were
embedded in collagen matrices and imaged by confocal
fluorescent microscopy (Fig. 1c-e). As expected, 3D
cultured T cells were completely surrounded by collagen
(Fig. 1c). The structure and density of collagen fibers
were clearly different in the matrices of different colla-
gen concentrations but no apparent morphological
changes were observed between T cells in 3D culture of
high or low collagen density (Fig. 1d-e). To examine if T
cell proliferation was affected by collagen density, T cells
were transiently PMA/ionomycin stimulated, CellTrace
Violet (CTV) labeled, and embedded in a high- or
low-density collagen matrix or cultured on regular tissue
culture plastic. Flow cytometry-based analysis of CTV
dilution in CD3+ cells showed a clear reduction in
proliferation when cells were cultured in 3D compared
to 2D. Interestingly, we also observed a smaller but still
significant reduction in proliferation when T cells
were cultured in a high-density collagen matrix com-
pared to a low-density collagen matrix (Fig. 1f-g).
This result was confirmed using a BrdU-based prolif-
eration assay (Fig. 1h). In consistence with other re-
ports [21, 48] we did not observe that proliferation of
cancer cell lines was similarly impaired in a high-density
collagen matrix (Fig. 1i).
The effects were similar for CD4+ and CD8+ T cells
(Additional file 1: Figure S1) and consistently the differ-
ent culture conditions did not change the ratio of CD4+
cells to CD8+ cells after 2 days in culture (Fig. 1j). How-
ever, after prolonged 3D culture of T cells for 5 days, the
ratio of CD4+ cells to CD8+ cells was higher in a
high-density matrix compared to a low-density matrix
(Fig. 1k), indicating that proliferation and/or survival is
slightly more impaired for CD8+ cells than for CD4+
cells in a high-density collagen matrix. Analysis of the
distribution of the different T cell differentiation subsets
after 5 days of 3D culture in a high- or low-density
collagen matrix or regular 2D culture (Additional file 1:
Figure S2) suggested an increase in effector memory T
cells and a decrease in central memory T cells after 3D
culture in a high-density collagen matrix compared to a
low-density collagen matrix.
To study if the reduced T cell proliferation in a
high-density collagen matrix could be reflected in the
differential abundance of tumor-infiltrating T cells in
breast tumors, we examined 20 samples of resected
triple-negative breast cancers, which were all of histo-
logical grade 3 and had a diameter between 10 and 20
mm. The samples were immunostained for CD8 and
picrosirius red-stained for fibrillar collagen (Fig. 2a-d).
Consistent with our 3D culture data, samples that
contained a high collagen density often had fewer infil-
trating CD8+ T cells, although this negative correlation
failed to reach statistically significance with this lim-
ited material (Fig. 2e). Analysis of the number of CD8
+ cells located in intratumoral regions of either high
or low collagen density within each tumor sample
(Additional file 1: Figure S3) also revealed a tendency
of fewer CD8+ T cells in regions of high collagen
density (Fig. 2f ).
The gene expression profile of T cells is regulated by
surrounding extracellular matrix
To further elucidate the response of T cells to 3D
culture in different collagen densities, T cells were 3D
cultured for 2 days in low- or high-density collagen
matrices or cultured on regular tissue culture plastic and
subjected to RNA sequencing. A principal component
analysis shows that the gene expression profile of cells
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Fig. 1 3D culture in high collagen density impairs T cell proliferation. a Schematic model of the 3D culture system. b T cells were cultured for 5
days in the indicated conditions, and subsequently viability was analyzed by flow cytometry. Each dot in the graph represents an individual
donor. Error bars indicate standard error of the mean (SEM). c-e T cells cultured in a collagen matrix of low density (1 mg/ml, c-d) or high density
(4 mg/ml, E) including fluorescently labeled collagen were imaged by confocal microscopy. c 3D projection of collagen matrix with embedded
T cells. d-e Representative images of individual T cells within a low- density collagen matrix (d) or high-density collagen matrix (e). Size bars:
(c-e) 10 μm. f-g T cell proliferation after 5 days in culture was measured by flow cytometry-based analysis of CellTrace Violet (CTV) dilution.
f Representative histogram showing CTV dilution in T cells cultured in 2D or in 3D in a low-density collagen matrix or high-density collagen
matrix. g Quantification of T cell proliferation based on CTV dilution. Three individual donors were analyzed. Connecting lines indicate
measurements of the same donor. h T cells were cultured in collagen gels of high and low density and their proliferation was measured using
a BrdU-based flow cytometry assay. The percentage of CD3-positive BrdU-positive cells is shown. i The breast cancer cell lines EO771.LMB,
MDA-MB-231, and 4 T1 were cultured in collagen matrices of low or high density for 5 days and analyzed using a BrdU-based flow cytometry
assay. The percentage of BrdU-positive cells is depicted. j-k The ratio of CD4+ to CD8+ cells was analyzed by flow cytometry after culture for 2
days (i) or 5 days (j). g-k Error bars indicate standard deviations of technical replicates
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cultured in 3D (low and high density) separate very
clearly from the 2D cultured cells (cultured on plastic)
and additionally that cells cultured in a high-density
collagen matrix cluster separately from cells cultured in
a low-density collagen matrix (Fig. 3a). The full gene
expression dataset is in Additional file 2: Table S1. The
clear difference between 2D and 3D culture was reflected
in 683 differentially regulated genes (FDR < 0.01 and fold
change > 1.5) for cells cultured in a low-density collagen
matrix compared to regular 2D culture on tissue culture
plastic (Fig. 3b and Additional file 1: Figure S4A) and
1928 differentially regulated genes (FDR < 0.01 and fold
change > 1.5) between culture in high-density collagen
compared to regular 2D culture (Additional file 1: Figure
S4B-C). In consistence with the reduced proliferation
(Fig. 1f-h), downregulated genes were involved in cell
cycle processes (Fig. 3c and Additional file 1: Figure S4E).
To investigate if T cell activity was affected by 3D culture,
we examined the expression levels of a panel of T cell
activity markers (Fig. 3d), regulatory T cell (Treg) markers
(Fig. 3e), and exhaustion markers (Fig. 3f). The heatmaps
did not show any clear 3D culture-induced changes in T
cell activity although some of the genes were indeed
significantly regulated, suggesting that 3D culture could
influence T cell biology. To identify putative transcription
factors (TFs) and TF families that may be responsible for
the differential gene expression observed after 3D culture
of T cells, we used the computational method ISMARA
(Integrated Motif Activity Response Analysis, https://
ismara.unibas.ch/mara/) to model transcription factor ac-
tivity [49]. Among the top-ranked identified downregu-
lated TF motifs, several known pro-proliferative factors
such as Myb and members of the E2F family were
included [50, 51] (Additional file 1: Figure S5). This is
consistent with the gene ontology analysis (Fig. 3c) and
the observed reduction in cellular proliferation after 3D
culture of T cells (Fig. 1f-h).
T cells cultured in a high-density collagen matrix
downregulate markers of cytotoxic activity
To investigate the gene regulation specifically induced
by collagen density, we compared T cells cultured in
high- vs. low-density collagen matrices and found that 351
genes were differentially expressed (FDR < 0.01 and fold
change > 1.5) (Fig. 4a and Additional file 1: Figure S4D).
In alignment with the observed collagen density-induced
reduction in proliferation (Fig. 1f-h), downregulated genes
were involved in cell cycle processes (Fig. 4b). Upregulated
A B E
C D F
Fig. 2 Breast cancer samples of high collagen density have fewer infiltrating T cells. a-d Histological sections of triple-negative breast cancers
were picrosirius red (PSR)-stained for visualization of fibrillar collagen (a and c, red color) or immunostained for CD8 for visualization of cytotoxic
T cells (B and D, brown color). a-b Example of a specimen containing low levels of collagen (a) and high abundance of tumor-infiltrating T cells
(b). c-d Example of a specimen containing high levels of collagen (c) and low abundance of tumor-infiltrating T cells (d). Size bar: (a and c) 1 mm;
(b and d) 100 μm. e Using Visiopharm-assisted automated image analysis, 20 triple-negative breast cancer sections were analyzed for the
PSR-positive area and the number of tumor-infiltrating CD8+ T cells. Each dot in the graph represents an individual cancer sample. Pearson
correlation r = 0.37, P = 0.11. f Areas of high and low collagen density were defined and the number of CD8+ T cells in these areas was assessed
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genes were involved in processes such as chemotaxis and
cell migration (Fig. 4b). Of the 10 most significantly up-
and down-regulated genes (Table 1), several have been
suggested to impact T cell activity. CD101, which is upreg-
ulated in a high-density matrix, has been suggested to be
involved in the negative regulation of T cell activity [52]
and the expression levels on Tregs correlate with their
immunosuppressive potency [53]. CIP2A, which is down-
regulated in a high-density matrix, has been suggested to
promote T cell activation [54].
To investigate the potential regulation of T cell activity
by collagen density, we visualized the regulation of a
panel of cytotoxic activity markers, exhaustion markers,
and markers of Tregs (Fig. 4c-e). Transcripts encoding
six out of seven T cell activity markers were significantly
downregulated by culture in high-density collagen
compared to low-density collagen (Fig. 4c). Only TNF
did not follow the same trend and was instead signifi-
cantly upregulated. At the same time Treg markers were






Fig. 3 Distinct transcriptomic signatures in 2D culture and in 3D culture in different collagen densities. a Principal component analysis of each
RNAseq replicate of T cells cultured on plastic (2D) or in 1 mg/ml (low density) or 4 mg/ml (high density) collagen matrices for 2 days. b MA plot
illustrating the differentially regulated genes (FDR < 0.01 and fold change > +/− 1.5) between cells cultured in a low-density collagen matrix or in
regular 2D culture. Genes that are upregulated in low-density collagen compared to 2D are shown in red and downregulated genes are shown
in blue. c Gene ontology analysis illustrates biological processes most significantly enriched within genes that are upregulated (left panel, red
bars) or downregulated (right panel, blue bars) in low density collagen compared to 2D. d-f Heatmaps of normalized (Z-score) RNAseq read
counts of genes encoding markers of T cell activity (d), Tregs (e), or T cell exhaustion (f). d-f Asterisks indicate significantly regulated genes
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exhaustion were not systematically regulated by colla-
gen density (Fig. 4e). To identify potential transcrip-
tional regulators of these effects, we again used
ISMARA to model TF activity. Among the top-ranked
downregulated TF motifs, we identified several E2F
motifs (Fig. 4f ), which is consistent with the observed
changes in cell proliferation. Among the top-ranked up-
regulated TF motifs, we identified SMAD4 and FOXO1
motifs (Fig. 4f), which are important mediators of TGF-β
induced Treg differentiation [55, 56]. In addition,
upregulated motifs include PML and FOXM1, which
have been suggested to be important for sustaining
TGF-β signaling [57, 58].
Altogether, the striking gene expression differences
induced by culture in high-density collagen compared to
low-density collagen suggests that the T cells acquire a
less cytotoxic and more regulatory phenotype.
All of the RNA sequencing experiments were performed
using PBMCs isolated from a single healthy donor. To
examine if the collagen-density induced gene regulations
were donor-specific or reflected a general regulatory






Fig. 4 A high-density matrix induces a transcriptomic program indicative of reduced proliferation and cytotoxic activity. a MA plot illustrating the
differentially regulated genes (FDR < 0.01 and fold change > +/− 1.5) between cells cultured in a high-density collagen matrix or a low-density
collagen matrix for 2 days. Genes that are upregulated in high-density collagen compared to low-density are shown in red and downregulated
genes are shown in blue. b Gene ontology analysis illustrates biological processes most significantly enriched within genes that are upregulated
(left panel, red bars) or downregulated (right panel, blue bars) in high density compared to low density. c-e Heatmaps of normalized (Z-score)
RNAseq read counts of genes encoding markers of T cell activity (c), Tregs (d), or T cell exhaustion (e). d-e Asterisks indicate significantly
regulated genes. f Heatmap of most significantly up- or downregulated TF motifs in high-density vs. low-density collagen
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observed in cells isolated from four additional healthy
donors. A panel of six transcripts, which were significantly
regulated by collagen-density in the RNA sequencing ex-
periments (two upregulated and four downregulated),
were analyzed by qRT-PCR and compared to the RNA
sequencing data (Fig. 5a-b). The gene-regulations followed
the same pattern as observed in the RNA sequencing
experiments, with four of the six genes showing a statisti-
cally significant regulation. This experiment as well as the
RNA sequencing was performed with PBMCs enriched
for T cells by excluding the strongly adherent fraction of
the PBMCs, and consequently approximately 70% of the
cells were T cells (data not shown). To investigate if the
remaining 30% cells, which include myeloid cells, could be
critical for mediating this effect of collagen-density we
purified T cells from PBMCs from four healthy donors
using magnetic anti-CD3 microbeads, resulting in a T cell
purity of more than 96% (data not shown). The purified T
cells were again transiently PMA/ionomycin-stimulated
and cultured in high-density collagen or low-density
collagen. Analysis by qRT-PCR of the six-gene panel
showed a similar pattern of gene-regulations, indicating
that T cells are directly affected by the surrounding colla-
gen density (Fig. 5c). The only gene that did not follow the
same pattern in the purified T cell was TNFRSF9, poten-
tially indicating the myeloid cells were involved in mediat-
ing the previously observed upregulation of TNFRSF9.
Analysis of purified CD8+ T cells after culture in collagen
of high or low density showed that cytotoxic CD8-positive
T cells responded to the surrounding collagen matrix in a
comparable manner as observed for total CD3+ T cells
(Fig. 5d). To investigate if TCR-stimulated T cells
responded similarly to the surrounding collagen density,
we co-cultured MAGE-A3 or MART-1 TCR-transduced
T cells together with the melanoma cell line FM82 [38]
within collagen matrices (Fig. 5e). Analysis of the
same six-gene panel showed a similar response as ob-
served for the purified T cells stimulated with PMA/
ionomycin (Fig. 5c-d).
Collagen density modulates the tumoricidal activity of
tumor-infiltrating T cells
To investigate if the collagen density-induced transcrip-
tional regulation of T cells was also reflected in an altered
cytotoxic activity, we used a matched set of cultured T
cells and melanoma cells isolated from the same tumor
fragment. The T cell culture from this patient (MM33) has
previously been shown to contain tumor-reactive T cells
and to have the ability to lyze autologous melanoma cells
[43]. The MM33 T cells were transiently PMA/ionomy-
cin-stimulated and 3D cultured for 2 days in a low-density
collagen matrix or a high-density collagen matrix or on
regular tissue culture plastic. Subsequently, the cells were
extracted from the matrices and assayed for their ability to
lyze melanoma cells in a standard four-hour Cr-51 release
assay (Fig. 6a). The incubation of melanoma cells with in-
creasing numbers of T cells led to increased cell lysis, but
the cytotoxic activity of the T cells was impaired after 3D
culture compared to 2D culture. Strikingly, cytotoxicity
was particularly low for T cells cultured in high-density
collagen matrix (Fig. 6a-b). The collagen density-induced
regulation of T cell cytotoxicity was also reflected in a
reduced level of secreted IFN-γ for the MM33 T cells
cultured in a high-density collagen matrix (Fig. 6c). In
these experiments, stimulation with PMA/ionomycin led
to noticeable cell death for a large fraction of the cells,
which is probably due to the preceding expansion of the
cells in high-dose IL-2 containing media. Therefore, we
also 3D cultured the T cell for 2 days without any stimula-
tion followed by extraction of cells for cytotoxicity
measurements (Fig. 6d). In this situation we also observed
a reduced cytotoxic activity of the T cells cultured in a
high-density collagen matrix compared to the T cells
cultured in a low-density collagen matrix (Fig. 6d-e). The
reduced cytotoxicity was again accompanied by reduced
secretion of IFN-γ, although it should be noted that IFN-γ
levels were much lower than for the PMA/ionomycin
treated T cells (Fig. 6f).
Table 1 Top up- or downregulated genes in high-density vs.
low-density collagen
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Fig. 5 (See legend on next page.)
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Taken together, our study reveals a novel immunosup-
pressive mechanism, which could be important for can-
cer progression and for cancer immunotherapy efficacy.
Discussion
Collagen density within tumors and their T cell infiltra-
tion comprise strong prognostic indicators of poor and
good prognosis, respectively. It has, however, not been
investigated if these two parameters are independent or
if they are interrelated. In this study, we used 3D culture
to address whether T cells respond to the surrounding
collagen matrix and if the collagen-density alters their
activity.
A first important observation made was that T cells in-
deed respond to their extracellular matrix environment.
This was reflected in a dramatically altered transcrip-
tional profile and reduced proliferation for 3D cultured
cells compared to regular 2D culture on tissue culture
plastic. Gene ontology analysis to identify biological
process categories that were statistically enriched con-
firmed that cell proliferation was significantly affected in
3D. This suggests that 3D culture models, which more
(See figure on previous page.)
Fig. 5 T cells from different donors respond similarly to the surrounding collagen density. a Bar graph of normalized (Z-score) RNAseq read
counts of a selected panel of differentially regulated genes. b-e Bar graphs of qRT-PCR analyses of the same panel of genes as in (a) in 3–4
different donors. Cultured cells were either PBMCs enriched for T cells (b), purified T cells (c), purified CD8+ cells (d) or TCR transduced T cells
(e) cultured for 2 days in a high-density collagen matrix or a low-density collagen matrix. f Table of correlation analyses between COL1A1 gene
and the same panel of genes as in (a) from a single-cell RNA sequencing dataset available in the Gene Expression Omnibus (GSE103322)
(a-f) Asterisks indicate significantly regulated genes
A B C
D E F
Fig. 6 Tumor-infiltrating T cells display reduced cytotoxicity after culture in a high-density collagen matrix. Tumor-infiltrating T cells from
melanoma MM33 were cultured for 3 days on plastic (2D) or in collagen matrices of high- or low density, after which the cells were assayed for
their ability to lyze autologous MM3 melanoma cells using a 51Cr-release assay. T cells were transiently PMA/ionomycin stimulated before the
culture period (a-c) or cultured without any stimulus (d-f). (a and d) Representative example of MM33 melanoma cell lysis after 4 h incubation
with different numbers of T cells, which had been transiently PMA/ionomycin stimulated (a) or directly embedded in collagen (d) and pre-
cultured as indicated. b Percentage of melanoma cell lysis at the highest T cell: melanoma cell ratio in 3 different experiments. The T cells had
been transiently PMA/ionomycin stimulated and cultured for 3 days in a low-density or high-density collagen matrix before extraction and
incubation with 51Cr-labeled MM33 melanoma cells. c and f IFNγ levels in conditioned media of MM33 T cells, which had been transiently
PMA/ionomycin stimulated (c) or directly embedded in collagen (f) and cultured for 3 days in a low-density or high-density collagen matrix.
e Percentage of melanoma cell lysis at the highest T cell: melanoma cell ratio in 5 different experiments. The T cells had been cultured for 3 days
in a low-density or high-density collagen matrix before extraction and incubation with 51Cr-labeled MM33 melanoma cells
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accurately mimic tissue environments, could be highly
relevant for studies of T cell biology. Although 3D
culture of T cells, compared to regular 2D culture, led to
a substantial change in the transcriptional profile, in-
spection of genes encoding markers of activation, Tregs,
or exhaustion did not reveal any obvious pattern in the
effects on T cell activity.
Another important observation in this study was that
T cells clearly respond to the density of the surrounding
collagen matrix. Culture of T cells within collagen-matri-
ces of either high or low density resulted in fewer differ-
entially regulated genes compared to the culture of T
cells in 2D vs. 3D but nevertheless resulted in striking
functional differences. A high collagen-density reduced
T cell proliferation and 5 days of culture in this matrix
favored CD4+ T cells over CD8+ T cells. A similar
reduction in cell proliferation was not observed for three
different breast cancer cell lines, suggesting that within a
tumor of high collagen density, T cell proliferation (espe-
cially CD8+ T cell proliferation) is impaired whereas
cancer cells are unaffected. In line with these observa-
tions, we observed in a limited number of triple-negative
breast cancer samples, that collagen density seemed to
negatively impact CD8+ T cell abundance. The effect of
collagen density on T cell proliferation could constitute
a new immunosuppressive mechanism within the tumor
microenvironment and provide an explanation for the
correlation between collagen density in tumors and
cancer patient prognosis.
In alignment with the effect of the surrounding
collagen density on T cell proliferation, inspection of
differentially regulated genes confirmed that cell cycle
processes were affected. In addition, markers of cyto-
toxic T cell activity were clearly downregulated by a
high-density collagen matrix compared to a low-density
matrix whereas markers of Tregs were upregulated. This
striking observation suggests that collagen density, in
addition to reducing T cell proliferation, impairs cyto-
toxic activity. Analysis of putative transcription factor
motifs, which could mediate the observed transcriptional
changes, identify decreased activity of E2F motifs and in-
creased activity of transcription factor motifs down-
stream of TGF-β signaling. These findings suggest that
E2F transcription factors could be involved in the colla-
gen density-induced inhibition of T cell proliferation and
that autocrine TGF-β signaling could be centrally
engaged in the modulation of T cell activity.
Using a unique T cell culture and melanoma cell
culture established from the same resected melanoma,
we could also demonstrate that the tumor-infiltrating T
cells were indeed less efficient at killing the melanoma
cells after culture in a high-density collagen matrix
compared to a low-density collagen matrix. This obser-
vation suggests that the collagen-density of the tumor
microenvironment can support the cancer cells’ escape
from immune destruction by reducing T cell prolifera-
tion and by modulating the cytotoxic activity of
tumor-infiltrating T cells. This identified immunosup-
pressive mechanism could be of relevance during tumor
progression but also have importance for the efficacy of
cancer immunotherapy.
Although this is the first study to directly assess the
response of T cells to the surrounding collagen density,
the potential of collagen to modulate immune activity is
supported by a study of tissue regeneration, in which
collagen implantation in wounded muscles of mice was
shown to induce an immunosuppressive microenviron-
ment [59]. This effect involved M2-polarization of
macrophages, which led to Th2-polarization of T cells.
In our study we focused on the ability of the surround-
ing collagen to directly regulate T cell activity, but it is
possible that collagen-induced M2-polarization of mac-
rophages could further augment this modulation of T
cells.
In addition to the effects of collagen-density on T cell
activity observed in this study, others have suggested
that stromal collagen could limit the migration of T cells
into the tumor islets and thereby impede their contact
with cancer cells [35, 36]. The impaired T cell migration
into tumor islets was suggested to be caused by reduced
motility in collagen-dense region combined with in-
appropriate guidance of T cells by the collagen fibers
aligned in parallel to tumor islets. These studies further
underscore that collagen within the tumor microenvir-
onment could be an important regulator of anti-cancer
immunity.
Conclusion
By using 3D culture of T cells, we have identified col-
lagen density as a novel regulator of anti-cancer T
cell activity. This immunosuppressive mechanism
could be of central importance for the cancer cells’
evasion of immune-destruction and could constitute a
novel therapeutic target for enhancing immunother-
apy efficacy.
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